Cargando…
5-α reductase inhibitors, benign prostatic hyperplasia, and risk of male breast cancer
PURPOSE: 5-α reductase inhibitors (5-ARI) have been suggested to increase the risk of male breast cancer. The aim of this study was to study the risk of breast cancer in men on 5-ARI, in men with benign prostatic hyperplasia (BPH) not on 5-ARI, and in men without BPH. METHODS: We performed a populat...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer International Publishing
2015
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4540753/ https://www.ncbi.nlm.nih.gov/pubmed/26109464 http://dx.doi.org/10.1007/s10552-015-0622-4 |